+39 02 610346.1 - info@newron.com Glossary | Sitemap Home About Us Research and Drug Development Investors and Media Contact Us Analyst Report ‹ › Discovering and developing innovative therapeutics for CNS disorders Welcome to the Newron Pharmaceuticals website. We are a clinical-stage biopharmaceutical company. Our shares are listed on the SIX Swiss Exchange (NWRN). Our mission is to discover, develop and commercialise novel drugs to treat diseases of the Central Nervous System (CNS) and pain. LATEST PRESS RELEASES 21 NOV Safinamide regulatory process in Europe on track 16 SEP Newron Pharmaceuticals reports half-year results 2014 29 JUL Refusal to File letter received from US FDA for safinamide, based on organization and navigation problems 11 JUL Newron shares to be included in the SXI Life Sciences® and the SXI Bio+Medtech® indices 8 JUL Newron establishes US operations 29 MAY Safinamide New Drug Application (NDA) submitted to the US Food and Drug Administration (FDA) View All NEWRON SHARE PRICE EVENTS 9 FEB 17th Annual BIO CEO & Investor Conference February 9-10, 2015 - The Waldorf Astoria, New York City, US 24 NOV German Equity Forum November 24-26, 2014 - Frankfurt-am-Main - Germany 5 NOV Vontobel Healthcare Tour November 5, 2014 - Zürich, Switzerland View Event Calendar About Us Overview Strategy Our people History Research & Drug Development Therapeutic Focus Pipeline Partners Publications Media News Events Reports, presentations & webcasts Email alert Investors Stock information Financial Calendar Financial Report Shareholder FAQs Disclaimer © Newron 2013. All Rights Reserved

+39 02 610346.1 - info@newron.com Glossary | Sitemap Home About Us Research and Drug Development Investors and Media Contact Us Analyst Report Senior Management Team About Us / Our People / Senior Management Team Overview Strategy Our People Board of Directors Senior Management Team History Senior management team Stefan Weber CEO view full profile Ravi Anand CMO view full profile Marco Caremi Executive VP Business Development view full profile Roberto Galli Vice President Finance view full profile Anders Haegerstrand General Manager Newron Sweden view full profile About Us Overview Strategy Our people History Research & Drug Development Therapeutic Focus Pipeline Partners Publications Media News Events Reports, presentations & webcasts Email alert Investors Stock information Financial Calendar Financial Report Shareholder FAQs Disclaimer © Newron 2013. All Rights Reserved